← Open Payments lookup

JESSICA WOO: Open Payments

NPI 1821611724 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$950 in 36 payments from 12 companies in 2025. Trend: 2023 $312 · 2024 $635 · 2025 $950

Food & beverage: $950
CompanyPaymentsAmount
Kowa Pharmaceuticals America, Inc.6$147
GlaxoSmithKline, LLC.7$140
AstraZeneca Pharmaceuticals LP1$125
Boehringer Ingelheim Pharmaceuticals, Inc.4$107
ABBVIE INC.5$100
Aimmune Therapeutics, Inc.2$85
Lilly USA, LLC3$81
Phathom Pharmaceuticals, Inc.3$54
Exact Sciences Corporation2$44
Merck Sharp & Dohme LLC1$23

Products named: ZORYVE, AIRSUPRA, AREXVY, ZENPEP, MOUNJARO, LINZESS, VOQUEZNA, OFEV.

Industry payments across CA — which companies pay providers there.